References
- Tefferi, A. (2000) "Myelofibrosis with myeloid metaplasia", QN. Engl. J. Med., 342(17), 1255–1265.
- Deeg, H.J., Gooley, T.A., Flowers, M.E., et al. (2003) "Allogeneic hemopoietic stem cell transplantation for myelofibrosis", Blood, 102(12), 3912–3918.
- Daly, A., Song, K., Nevill, T., et al. (2003) "Stem cell transplanta-tion for myelofibrosis: a report from two Canadian centers", Bone Marrow Transplant, 32(1), 35–40.
- Guardiola, P., Anderson, J.E., Bandini, G., et al. (1999) "Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study", Blood, 93(9), 2831–2838.
- Hessling, J., Kroger, N., Werner, M., et al. (2002) "Dose-reduced conditioning regimen followed by allogeneic stem cell transplanta-tion in patients with myelofibrosis with myeloid metaplasia", Br. J. HaematoL, 119(3), 769–772.
- Devine, S.M., Hoffman, R., Verma, A., et al. (2002) "Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia", Blood, 99(6), 2255–2258.
- Dupriez, B., Morel, P., Demory, J.L., et al. (1996) "Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system", Blood, 88(3), 1013–1018.
- Snover, D.C. (1989) "Biopsy interpretation in bone marrow transplantation", PathoL Annu., 24\(Pt 2), 63–101.
- Towell, B.L. and Levine, S.P. (1987) "Massive hepatomegaly following splenectomy for myeloid metaplasia. Case report and review of the literature", Am. J. Med., 82(2), 371–375.
- Dey, B., McAfee, S., Sackstein, R., et al. (2001) "Achievement of sustained remissions despite loss of donor chimerism (DC) in patients with chemotherapy-refractory non-Hodgkin's lymphoma (NHL) treated with nonmyeloablative conditioning and allogeneic stem cell transplantation (SCT) [abstract]", Blood, 98, 1753a.
- Rubio, M.T., Kim, Y.M., Sachs, T., et al. (2003) "Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma", Blood, 102(6), 2300–2307.